|
1
|
Liu N, Jiang N, Guo R, Jiang W, He QM, Xu
YF, Li YQ, Tang LL, Mao YP, Sun Y, et al: MiR-451 inhibits cell
growth and invasion by targeting MIF and is associated with
survival in nasopharyngeal carcinoma. Mol Cancer. 12:1232013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aga M, Bentz GL, Raffa S, Torrisi MR,
Kondo S, Wakisaka N, Yoshizaki T, Pagano JS and Shackelford J:
Exosomal HIF1α supports invasive potential of nasopharyngeal
carcinoma-associated LMP1-positive exosomes. Oncogene.
33:4613–4622. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Krutilina R, Sun W, Sethuraman A, Brown M,
Seagroves TN, Pfeffer LM, Ignatova T and Fan M: MicroRNA-18a
inhibits hypoxia-inducible factor 1α activity and lung metastasis
in basal breast cancers. Breast Cancer Res. 16:R782014. View Article : Google Scholar
|
|
4
|
Long Z, Wang B, Tao D, Huang Y and Tao Z:
Hypofractionated radiotherapy induces miR-34a expression and
enhances apoptosis in human nasopharyngeal carcinoma cells. Int J
Mol Med. 34:1388–1394. 2014.PubMed/NCBI
|
|
5
|
Zhou W, Fong MY, Min Y, Somlo G, Liu L,
Palomares MR, Yu Y, Chow A, O'Connor ST, Chin AR, et al:
Cancer-secreted miR-105 destroys vascular endothelial barriers to
promote metastasis. Cancer Cell. 25:501–515. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Suh YE, Raulf N, Gäken J, Lawler K, Urbano
TG, Bullenkamp J, Gobeil S, Huot J, Odell E and Tavassoli M:
MicroRNA-196a promotes an oncogenic effect in head and neck cancer
cells by suppressing annexin A1 and enhancing radioresistance. Int
J Cancer. 137:1021–1034. 2014. View Article : Google Scholar
|
|
7
|
Huang XH, Chen JS, Wang Q, Chen XL, Wen L,
Chen LZ, Bi J, Zhang LJ, Su Q and Zeng WT: miR-338–3p suppresses
invasion of liver cancer cell by targeting smoothened. J Pathol.
225:463–472. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu ZJ, Lu LG, Tao KZ, Chen DF, Xia Q, Weng
JJ, Zhu F, Wang XP and Zheng P: MicroRNA-185 suppresses growth and
invasion of colon cancer cells through inhibition of the
hypoxia-inducible factor-2α pathway in vitro and in vivo. Mol Med
Rep. 10:2401–2408. 2014.PubMed/NCBI
|
|
9
|
Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang
J, McCarthy JB, She X, Zhang W, Ma J, et al: miR-18a promotes
malignant progression by impairing microRNA biogenesis in
nasopharyngeal carcinoma. Carcinogenesis. 34:415–425. 2013.
View Article : Google Scholar
|
|
10
|
Liu N, Tang LL, Sun Y, Cui RX, Wang HY,
Huang BJ, He QM, Jiang W and Ma J: MiR-29c suppresses invasion and
metastasis by targeting TIAM1 in nasopharyngeal carcinoma. Cancer
Lett. 329:181–188. 2013. View Article : Google Scholar
|
|
11
|
Zhang JX, Qian D, Wang FW, Liao DZ, Wei
JH, Tong ZT, Fu J, Huang XX, Liao YJ, Deng HX, et al: MicroRNA-29c
enhances the sensitivities of human nasopharyngeal carcinoma to
cisplatin-based chemotherapy and radiotherapy. Cancer Lett.
329:91–98. 2013. View Article : Google Scholar
|
|
12
|
Alajez NM, Lenarduzzi M, Ito E, Hui AB,
Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, et al: MiR-218
suppresses nasopha-ryngeal cancer progression through
downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res.
71:2381–2391. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu J, He ML, Wang L, Chen Y, Liu X, Dong
Q, Chen YC, Peng Y, Yao KT, Kung HF, et al: MiR-26a inhibits cell
growth and tumorigenesis of nasopharyngeal carcinoma through
repression of EZH2. Cancer Res. 71:225–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ji Y, He Y, Liu L and Chong X: MiRNA-26b
regulates the expression of cyclooxygenase-2 in
desferrioxamine-treated CNE cells. FEBS Lett. 584:961–967. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Deng M, Tang H, Zhou Y, Zhou M, Xiong W,
Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, et al: miR-216b suppresses
tumor growth and invasion by targeting KRAS in nasopharyngeal
carcinoma. J Cell Sci. 124:2997–3005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li G, Wu Z, Peng Y, Liu X, Lu J, Wang L,
Pan Q, He ML and Li XP: MicroRNA-10b induced by Epstein-Barr
virus-encoded latent membrane protein-1 promotes the metastasis of
human nasopharyngeal carcinoma cells. Cancer Lett. 299:29–36. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang L, Deng T, Li X, Liu H, Zhou H, Ma
J, Wu M, Zhou M, Shen S, Li X, et al: microRNA-141 is involved in a
nasopharyngeal carcinoma-related genes network. Carcinogenesis.
31:559–566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xia H, Ng SS, Jiang S, Cheung WK, Sze J,
Bian XW, Kung HF and Lin MC: miR-200a-mediated downregulation of
ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma
cell growth, migration and invasion. Biochem Biophys Res Commun.
391:535–541. 2010. View Article : Google Scholar
|
|
19
|
Guo B, Liu L, Yao J, Ma R, Chang D, Li Z,
Song T and Huang C: miR-338–3p suppresses gastric cancer
progression through a PTEN-AKT axis by targeting P-REX2a. Mol
Cancer Res. 12:313–321. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang XH, Wang Q, Chen JS, Fu XH, Chen XL,
Chen LZ, Li W, Bi J, Zhang LJ, Fu Q, et al: Bead-based microarray
analysis of microRNA expression in hepatocellular carcinoma:
miR-338 is downregulated. Hepatol Res. 39:786–794. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Caramuta S, Egyházi S, Rodolfo M, Witten
D, Hansson J, Larsson C and Lui WO: MicroRNA expression profiles
associated with mutational status and survival in malignant
melanoma. J Invest Dermatol. 130:2062–2070. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peng Y, Liu YM, Li LC, Wang LL and Wu XL:
MicroRNA-338 inhibits growth, invasion and metastasis of gastric
cancer by targeting NRP1 expression. PLoS One. 9:e944222014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kucharzewska P, Christianson HC, Welch JE,
Svensson KJ, Fredlund E, Ringnér M, Mörgelin M, Bourseau-Guilmain
E, Bengzon J and Belting M: Exosomes reflect the hypoxic status of
glioma cells and mediate hypoxia-dependent activation of vascular
cells during tumor development. Proc Natl Acad Sci USA.
110:7312–7317. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Y, Li X, Wu S, Xu G, Zhou Y, Gong L,
Li Z and Yang D: Expression of HIF-1α and CAIX in nasopharyngeal
carcinoma and their correlation with patients' prognosis. Med
Oncol. 31:3042014. View Article : Google Scholar
|
|
25
|
Pan WL, Wong JH, Fang EF, Chan YS, Ng TB
and Cheung RC: Preferential cytotoxicity of the type I ribosome
inactivating protein alpha-momorcharin on human nasopharyngeal
carcinoma cells under normoxia and hypoxia. Biochem Pharmacol.
89:329–339. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xueguan L, Xiaoshen W, Yongsheng Z, Chaosu
H, Chunying S and Yan F: Hypoxia inducible factor-1 alpha and
vascular endothelial growth factor expression are associated with a
poor prognosis in patients with nasopharyngeal carcinoma receiving
radiotherapy with carbogen and nicotinamide. Clin Oncol (R Coll
Radiol). 20:606–612. 2008. View Article : Google Scholar
|
|
27
|
Hui EP, Chan AT, Pezzella F, Turley H, To
KF, Poon TC, Zee B, Mo F, Teo PM, Huang DP, et al: Coexpression of
hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX,
and vascular endothelial growth factor in nasopharyngeal carcinoma
and relationship to survival. Clin Cancer Res. 8:2595–2604.
2002.PubMed/NCBI
|
|
28
|
Xu H, Zhao L, Fang Q, Sun J, Zhang S, Zhan
C, Liu S and Zhang Y: MiR-338–3p inhibits hepatocarcinoma cells and
sensitizes these cells to sorafenib by targeting hypoxia-induced
factor 1α. PLoS One. 9:e1155652014. View Article : Google Scholar
|
|
29
|
Mak P, Leav I, Pursell B, Bae D, Yang X,
Taglienti CA, Gouvin LM, Sharma VM and Mercurio AM: ERbeta impedes
prostate cancer EMT by destabilizing HIF-1alpha and inhibiting
VEGF-mediated snail nuclear localization: Implications for Gleason
grading. Cancer Cell. 17:319–332. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fischer C, Leithner K, Wohlkoenig C,
Quehenberger F, Bertsch A, Olschewski A, Olschewski H and Hrzenjak
A: Panobinostat reduces hypoxia-induced cisplatin resistance of
non-small cell lung carcinoma cells via HIF-1α destabilization. Mol
Cancer. 14:42015. View Article : Google Scholar
|
|
31
|
Du R, Sun W, Xia L, Zhao A, Yu Y, Zhao L,
Wang H, Huang C and Sun S: Hypoxia-induced down-regulation of
microRNA-34a promotes EMT by targeting the Notch signaling pathway
in tubular epithelial cells. PLoS One. 7:e307712012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun K, Deng HJ, Lei ST, Dong JQ and Li GX:
miRNA-338–3p suppresses cell growth of human colorectal carcinoma
by targeting smoothened. World J Gastroenterol. 19:2197–2207. 2013.
View Article : Google Scholar :
|
|
33
|
Bao B, Azmi AS, Ali S, Ahmad A, Li Y,
Banerjee S, Kong D and Sarkar FH: The biological kinship of hypoxia
with CSC and EMT and their relationship with deregulated expression
of miRNAs and tumor aggressiveness. Biochim Biophys Acta.
1826:272–296. 2012.PubMed/NCBI
|
|
34
|
King HW, Michael MZ and Gleadle JM:
Hypoxic enhancement of exosome release by breast cancer cells. BMC
Cancer. 12:4212012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ruan K, Song G and Ouyang G: Role of
hypoxia in the hallmarks of human cancer. J Cell Biochem.
107:1053–1062. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou J, Li K, Gu Y, Feng B, Ren G, Zhang
L, Wang Y, Nie Y and Fan D: Transcriptional up-regulation of RhoE
by hypoxia-inducible factor (HIF)-1 promotes epithelial to
mesenchymal transition of gastric cancer cells during hypoxia.
Biochem Biophys Res Commun. 415:348–354. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Luo Z, Bai M, Xiao X, Zhang W, Liu X, Yang
X, Li S, Huan Y, Wu Z, Zhang X, et al: Silencing of HIF-1α enhances
the radiation sensitivity of human glioma growth in vitro and in
vivo. Neuropharmacology. 89:168–174. 2015. View Article : Google Scholar
|
|
38
|
Li X, Zhang Z, Beiter T and Schluesener
HJ: Nanovesicular vaccines: Exosomes. Arch Immunol Ther Exp
(Warsz). 53:329–335. 2005.
|
|
39
|
Zhang L, Huang G, Li X, Zhang Y, Jiang Y,
Shen J, Liu J, Wang Q, Zhu J, Feng X, et al: Hypoxia induces
epithelial-mesenchymal transition via activation of SNAI1 by
hypoxia-inducible factor -1α in hepatocellular carcinoma. BMC
Cancer. 13:1082013. View Article : Google Scholar
|
|
40
|
Meijer TW, Kaanders JH, Span PN and
Bussink J: Targeting hypoxia, HIF-1, and tumor glucose metabolism
to improve radiotherapy efficacy. Clin Cancer Res. 18:5585–5594.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sasabe E, Zhou X, Li D, Oku N, Yamamoto T
and Osaki T: The involvement of hypoxia-inducible factor-1alpha in
the susceptibility to gamma-rays and chemotherapeutic drugs of oral
squamous cell carcinoma cells. Int J Cancer. 120:268–277. 2007.
View Article : Google Scholar
|
|
42
|
Zhang P, Liu H, Xia F, Zhang QW, Zhang YY,
Zhao Q, Chao ZH, Jiang ZW and Jiang CC: Epithelial-mesenchymal
transition is necessary for acquired resistance to cisplatin and
increases the metastatic potential of nasopharyngeal carcinoma
cells. Int J Mol Med. 33:151–159. 2014.
|
